Noninvasive prenatal diagnosis: 2010

Clinics in Laboratory Medicine

Volumn 30, Issue 3, 2010, Pages 655-665

  Evans, Mark I ^a,b,c   Kilpatrick, Michael ^d  

^a Fetal Medicine Foundation of America   (United States)

^b Comprehensive Genetics ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Ikonisys Inc   (United States)

Author keywords

Cell free fetal DNA RNA; Fetal cells; Noninvasive prenatal diagnosis

Indexed keywords

DNA; RHESUS D ANTIBODY; RNA;

ALLELE; ANEUPLOIDY; CELL FREE SYSTEM; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; FETUS CELL; FETUS ECHOGRAPHY; GENE SEQUENCE; HEMOLYTIC ANEMIA; HUMAN; JURISPRUDENCE; MATERNAL AGE; MATERNAL SERUM; MEDICOLEGAL ASPECT; MENDELIAN DISORDER; MONOGENIC DISORDER; NON INVASIVE PROCEDURE; PATIENT DECISION MAKING; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; RHESUS INCOMPATIBILITY; RHESUS ISOIMMUNIZATION; RISK FACTOR; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; SRY GENE; TROPHOBLAST; CHEMISTRY; CYTOLOGY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; MASS SCREENING; PREGNANCY; RISK ASSESSMENT; UTERINE CERVIX;

CERVIX UTERI; DNA; FEMALE; FETUS; HUMANS; MASS SCREENING; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; RNA; TROPHOBLASTS;

EID: 77954781300     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.04.011     Document Type: Review

References (48)

1. Prenatal diagnosis: genetics, reproductive risks, testing, and management 2006, McGraw Hill Publishing Co, New York. M.I. Evans, M.P. Johnson, Y. Yaron (Eds.).
2. Evans M.I., Wapner R.J. Invasive prenatal diagnostic procedures 2005. Semin Perinatol 2005, 29(4):215-218.
3. Evans M.I., Krivchenia E.L., Wapner R.J., et al. Principles of screening. Clinical obstetrics and gynecology - new genetics for the clinician 2002, 657-660. Lippincott, Williams & Wilkins, Philadelphia. M.I. Evans (Ed.).
4. Evans MI, Andriole S. Screening and testing in multiples. In: Odibo A, Krantz DA, editors. Prenatal screening and diagnosis clinics in laboratory medicine. Philadelphia: Elsevier Saunders Publishing C, in press.
5. Bianchi D.W., Simpson J.L., Jackson L.G., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I Data. Prenat Diagn 2002, 22:609-615.
6. Herzenberg L.A., Bianchi D.W., Schroeder J., et al. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A 1979, 76:1453-1455.
7. Fetal cells and fetal DNA in maternal blood: new developments for a new millennium 2001, Karger Publishing Co, Basel (Switzerland). S. Hahn, W. Holzgreve (Eds.).
8. Holzgreve W., Zhong X.Y., Troeger C., et al. Fetal cells in maternal blood: an overview of the basel experience. Fetal cells and fetal DNA in maternal blood: new developments for a new millennium 2001, 28-36. Karger Publishing Co, Basel (Switzerland). S. Hahn, W. Holzgreve (Eds.).
9. Lo Y.M.D., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1999, 64:218-224.
10. Lo Y.M.D., Tsui N.B.Y., Leung T.Y., et al. Development of extraction protocols to improve the yield for fetal RNA in maternal plasma. Nat Med 2007, 13:218-223.
11. Moise K.J. Management of Rhesus alloimmunization in pregnancy. Obstet Gynecol 2008, 112:164-176.
12. Evans M.I., Hyett J., Nicolaides K.H. Genetic screening and clinical testing. High risk obstetrics in the requisites in obstetrics and gynecology 2008, 33-60. Elsevier Science, Philadelphia. E. Funai, M.I. Evans, J. Lockwood (Eds.).
13. Bischoff F., Hahn S., Johnson K., et al. Intact fetal cells in maternal plasma: are they really there?. Lancet 2003, 361:139-140.
14. Kilpatrick M.W., Tafas T., Evans M.I., et al. Getting fetal cells in maternal blood to work: eliminating the false positive XY signals in XX pregnancies. Am J Obstet Gynecol 2004, 190:1571-1581.
15. Seppo A., Frisova V., Ichetovkin I., et al. Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies. Prenat Diagn 2008, 28(9):815-821.
16. Huang R., Barber T.A., Schmidt M.A., et al. A microfluidics approach for the solation of nucleated red blood cells (NRBCs) from peripheral blood of pregnant women. Prenat Diagn 2008, 28:892-899.
17. Burgemeister R. New aspects of laser microdissection in research and routine. J Histochem Cytochem 2005, 53:409-412.
18. Adinolfi M., Sherlock J. First trimester prenatal diagnosis using transcervical cells: an evaluation. Hum Reprod Update 1997, 3:383-392.
19. Fejgin M.D., Diukman R., Cotton Y., et al. Fetal cells in the uterine cervix: a source for early non-invasive prenatal diagnosis. Prenat Diagn 2001, 21:619-621.
20. Bussani C., Cioni R., Scarselli B., et al. Strategies for the isolation and detection of fetal cells in transcervical samples. Prenat Diagn 2002, 22:1098-1101.
21. Cioni R., Bussani C., Scarselli B., et al. Comparison of two techniques for transcervical cell sampling performed in the same study population. Prenat Diagn 2005, 25:198-202.
22. Rodeck C., Tutschek B., Sherlock J., et al. Methods for the transcervical collection of fetal cells during the first trimester of pregnancy. Prenat Diagn 1995, 15:933-942.
23. Massari A., Novelli G., Colosimo A., et al. Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells. Hum Genet 1996, 97:150-155.
24. Katz-Jaffe M.G., Mantzaris D., Cram D.S. DNA identification of fetal cells isolated from cervical mucus: potential for early non-invasive prenatal diagnosis. BJOG 2005, 112:595-600.
25. Lo Y.M.D., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
26. Chan K.C.A., Zhang J., Jui A.B., et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004, 50:88-92.
27. Li Y., DiNaro E., Vitucci A., et al. Detection of paternally inherited fetal point mutations for beta-thalassemia using size fractionated cell free DNA in maternal plasma. JAMA 2005, 293:843-849.
28. Poon L.L.M., Leung T.N., Lau T.K., et al. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002, 48:35-41.
29. Chim S.S.C., Tong Y.K., Chiu R.W.K., et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Clin Chem 2002, 48:35-41.
30. Lo Y.M.D. Non invasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. Br J Obstet Gynaecol 2009, 116:152-157.
31. Available at:, Accessed June 1, 2010. http://finance.yahoo.com/news/Sequenom-Announces-Settlement-prnews-939367606.html%3Fx%3D0%26.v%3D1.
32. Lo Y.M.D., Lun F.M.F., Chan K.C.A., et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A 2007, 104:13116-13121.
33. Fan H.C., Blumenfeld Y.J., El-Sayed Y.Y., et al. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am J Obstet Gynecol 2009, 200:543. e1-543.e7.
34. Vogelstein B., Kintzler K.W. Digital PCR. Proc Natl Acad Sci U S A 1999, 96:9236-9241.
35. Hahn S., Jackson L.G., Kolla V., et al. Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn 2009, 9:613-621.
36. Fan H.C., Blumenfeld Y.J., Chirkara U., et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008, 105:16266-16271.
37. Chiu R.W., Chan K.C., Gao Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008, 105:20458-20463.
38. Geifman-Holtzman O., Grotegut C.A., Gaughan J.P. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta analysis. Am J Obstet Gynecol 2006, 195:1163-1173.
39. Brown S., Kellner L.H., Munson M., et al. Non-invasive prenatal testing: technical strategies to achieve testing of cell free fetal DNA RhD genotype in a clinical lab. Am J Obstet Gynecol 2007, 197:S173.
40. Chiu R.W.K., Lau T.K., Leung T.N., et al. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002, 360:998-1000.
41. Li Y., Page-Christiaens G.C., Gille J.J., et al. Non-invasive prenatal detection of achondroplasia in size fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007, 27:11-17.
42. Scheffer P.G., van der Schoot C.E., Godelieve C.M.L., et al. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010, 115:117-126.
43. Baker C., Feldman B., Shalhoub A.G., et al. Demographic factors for utilization of invasive genetic testing after multifetal pregnancy reduction (MFPR). Fetal Diagn Ther 2003, 18:140-143.
44. Abuhamad A., Chaoui R. A practical guide to fetal echocardiography 2010, Wolters Kluwer/Lippincott, Philadelphia. 2nd edition.
45. Malone F.D., Canick J.A., Ball R.H., et al. First trimester or second trimester screening or both for Down's Syndrome. N Engl J Med 2005, 353:2001-2011.
46. Henry G.P., Britt D.W., Evans M.I. Screening advances and diagnostic choice: the problem of residual risk. Fetal Diagn Ther 2008, 23:308-315.
47. Evans M.I., Pergament E. Impact of quality of nuchal translucency measurements on detection rates of Trisomies 13 and 18. Fetal Diagn Ther 2010, 27:68-71.
48. Zamerowski S.T., Lumley M.A., Arreola R.A., et al. Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood. Genet Med 2001, 4:301-309.